SA
MRK icon

Sicart Associates’s Merck MRK Stock Holding History

Sicart Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-89,677
Closed -$9.61M – 71
2023
Q1 		$9.61M Sell
89,677
-13,148
-13% -$1.42M 3.74% 7
2022
Q4 		$11.5M Sell
102,825
-710
-0.7% -$72.6K 4.05% 6
2022
Q3 		$8.99M Sell
103,535
-20,257
-16% -$1.81M 3.19% 9
2022
Q2 		$11.4M Buy
123,792
+1,402
+1% +$124K 3.54% 7
2022
Q1 		$10.1M Sell
122,390
-3,728
-3% -$294K 2.62% 13
2021
Q4 		$9.82M Buy
126,118
+6,027
+5% +$480K 2.56% 14
2021
Q3 		$9.1M Sell
120,091
-13,050
-10% -$993K 2.48% 16
2021
Q2 		$10.4M Buy
133,141
+57,920
+77% +$4.31M 2.48% 15
2021
Q1 		$5.58M Sell
75,221
-5,298
-7% -$391K 1.48% 24
2020
Q4 		$6.33M Sell
80,519
-1,217
-1% -$93.1K 1.56% 21
2020
Q3 		$6.52M Sell
81,736
-1,414
-2% -$111K 1.95% 16
2020
Q2 		$6.18M Sell
83,150
-1,137
-1% -$85.6K 1.98% 13
2020
Q1 		$6.24M Sell
84,287
-4,339
-5% -$341K 2.38% 11
2019
Q4 		$7.74M Sell
88,626
-3,894
-4% -$320K 2.58% 11
2019
Q3 		$7.48M Buy
92,520
+3,514
+4% +$282K 2.46% 13
2019
Q2 		$7.17M Sell
89,006
-3,851
-4% -$295K 2.91% 10
2019
Q1 		$7.42M Sell
92,857
-498
-0.5% -$37.2K 3.13% 8
2018
Q4 		$6.86M Sell
93,355
-82
-0.1% -$5.79K 3.32% 9
2018
Q3 		$6.37M Hold
93,437
– – 3.05% 9
2018
Q2 		$5.45M Buy
93,437
+76,117
+439% +$4.29M 2.86% 9
2018
Q1 		$908K Sell
17,320
-25,446
-60% -$1.37M 0.54% 45
2017
Q4 		$2.31M Buy
42,766
+5,240
+14% +$290K 1.22% 23
2017
Q3 		$2.29M Hold
37,526
– – 1.64% 17
2017
Q2 		$2.29M Hold
37,526
– – 1.67% 18
2017
Q1 		$2.27M Buy
37,526
+1,048
+3% +$63.6K 1.64% 17
2016
Q4 		$2.05M Buy
+36,478
New +$2.13M 1.41% 24

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sicart Associates's MRK Position: Q2 2023 in Review

Sicart Associates sold out of Merck (MRK) in Q2 2023, closing a stake of 89,677 shares — an estimated $9.61M sold.

Sicart Associates first reported a position in MRK in Q4 2016 and held it in 26 quarters. The position peaked at $11.5M in Q4 2022. 3,256 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

  • Sicart Associates reported no remaining Merck position as of Q2 2023 after selling out during the quarter.
  • Sicart Associates sold 89,677 Merck shares in Q2 2023, an estimated $9.61M.
  • Sicart Associates first reported a position in Merck in Q4 2016 and held it in 26 quarters.
  • Sicart Associates's Merck position peaked at $11.5M in Q4 2022.
  • 3,256 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on Sicart Associates's 13F filing for Q2 2023, filed 28 Jul 2023.